RxDoctor Payments Data

Kiri Rutledge, OD

Optometrist · Daytona Beach, FLNPI 1689141889

Payments from drug & device makers

$3,273in general payments, 2019–2025

Across 175 payments — averaging $18.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$684
  • Kala Pharmaceuticals, Inc.$408
  • Novartis$374
  • Alcon$271
  • Bausch & Lomb Americas Inc.$217
  • Tarsus Pharmaceuticals, Inc.$202
  • plus $1K from 10 others

What the payments were for

  • Food & beverage$3,273100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,273 in reported general payments places this provider in the 80th percentile of 3,166 optometrist providers in Florida.

See all optometrist providers in Florida

Medicare billing

Part B allowed, 2024
$333,440
Medicare patients
1,361
Services billed
4,076

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine54$75,010
XiidraLifitegrast40$57,163
MieboPerfluorohexyloctane/Pf27$21,611
Cyclosporine40$17,335
Latanoprost325$5,239
Prednisolone Acetate68$2,724
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha224$2,509
Loteprednol Etabonate12$2,387
Timolol Maleate121$2,188
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol16$2,135
Bimatoprost15$1,320
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat73$1,187
ErythromycinErythromycin Base79$831
Tobramycin-DexamethasoneTobramycin/Dexamethasone18$722
MoxifloxacinMoxifloxacin Hcl38$673

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Bausch & Lomb Americas Inc.Xiidra, Miebo$217$78,77467 claims
AbbVieRestasis$684$75,01054 claims
Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate$132$2,38712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,166 optometrist providers in Florida.

Other optometrist in Daytona Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →